Industries > Pharma > Pharma Wholesale and Distribution Market Forecasts 2017-2027

Pharma Wholesale and Distribution Market Forecasts 2017-2027

Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China

PUBLISHED: 22 June 2017
PAGES: 265
PRODUCT CODE: PHA0205

Clear
WOOCS 2.2.1
SKU: PHA0205 Categories: , ,

The pharma wholesale and distribution market is estimated at $893.69 million in 2016 and is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.2% from 2017-2027. In 2016, the branded drugs submarket held 79.5% share of the pharma wholesale and distribution market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 265-page report you will receive 83 tables and 97 figures – all unavailable elsewhere.

The 265-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Pharma Wholesale and Distribution market forecasts from 2017-2027

• This report also breaks down the revenue forecast for main submarkets:
– Branded Drugs
– Generic Drugs
– Other Medicines

• This report provides individual revenue forecasts to 2027 for these national markets:
– The US
– Japan
– Germany
– France
– Italy
– Spain
– The UK
– China
– Brazil
– Russia
– India

Pharma Wholesale and Distribution Market Forecasts 2017-2027

• Our study includes SWOT and STEP analysis of this industry and market.

• Our study discusses the selected leading companies that are the major players in the pharma wholesale and distribution industry:
– McKesson
– Cardinal Health
– AmerisourceBergen
– Walgreens Boots Alliance
– MEDIPAL HOLDINGS
– The PHOENIX Group
– SINOPHARM
– Alfresa Holdings
– SUZUKEN
– Shanghai Pharmaceutical Holdings

• Our report explains issues, events and shifts affecting that industry and market from 2016, including these influences:
– Roles of pharmaceutical wholesalers – activities, changes and prospects
– Revenues, costs and profits
– Direct-to-pharmacy (DTP) activities
– Full-line wholesalers (FLWs), short-line wholesalers (SLWs) and the drug distribution chain, including logistical service providers
– Technologies and services – progress in supplying pharmacies, clinics and hospitals, serving healthcare professionals, governments, payers and patients
– Forward buying, fee-for-service systems and the rise of retail pharmacies.

• Our investigation also discusses other aspects of that industry, including these forces:
– Parallel trade – activities, policies, challenges and effects
– Inventory management agreements, clawback, reimbursement and discounts
– Rise of specialty medicines, including biologics, vaccines and biosimilars – opportunities for intermediaries, including cold chain distribution networks
– Actions against drug counterfeiting – security of pharmaceutical supply chains
– Changes to regulations and healthcare budgets – policies affecting trade

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.

Buy our report today Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2017-2027


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories